CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Cited by
Items 901–1,000 of 1,000
A redox switch regulates the assembly and anti-CRISPR activity of AcrIIC1
Zhao, Y., Hu, J., Yang, S., Zhong, J., Liu, J., Wang, S., Jiao, Y., Jiang, F., Zhai, R., Ren, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34551-8 · Cited by 7
Utebayev, M., Dolinny, Y., Дашкевич, С., & Bome, N. A. (2022) · SABRAO Journal of Breeding and Genetics · doi:10.54910/sabrao2022.54.4.7 · Cited by 7
“The newest technique was genome editing with the CRISPR/Cas9 system (Knott and Doudna, 2018), which helps create lowgluten wheat lines (Sánchez-León et al., 2018), required for the nutrition of people with an allergic reaction—gluten enteropathy caused by certain fractions of gliadin (Palosuo et…”
BackgroundMethodGenome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis
Wu, W., Ma, G., Qi, H., Dong, L., Chen, F., Wang, Y., Mao, X., Guo, X., Cui, J. Z., Matsubara, J. A., et al. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.079 · Cited by 8
“18,21 Recently genome editing has been employed to deplete crucial genes to treat pathological conditions in a variety of animal models.”
Tang, Q., Hu, Z., Zhao, J., Zhou, T., Tang, S., Wang, P., Xiao, R., Chen, Y., Wu, L., Zhou, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109013 · Cited by 8
“Given the conceptual simplicity, specificity, high efficiency, and low toxicity, clustered regularly interspaced short palindromic repeats-associated proteins (CRISPR/Cas) systems have become the most attractive tool for gene engineering and are promising for the treatment of genetic disorders including HB [23,24].”
BackgroundHu, W., Yang, B., Xiao, Q., Wang, Y., Shuai, Y., Zhao, G., Zhang, L., Deng, Z., He, X., & Liu, G. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad743 · Cited by 7
“Many worthwhile techniques have been de v eloped from restriction systems, among which genome editing is regarded as an efficient tool for correction of genetic mutations and treatment of numerous diseases ( 17 , 18 ).”
MethodDevelopment of a CRISPR/Cas12a-based method to detect invasive aquatic species
Zhang, M., Zuo, X., Liang, J., Lu, K., Wei, L., Xu, Y., Zhao, H., Gan, S., Wu, J., & Wang, Q. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741132 · Cited by 7
Model systems inform rare disease diagnosis, therapeutic discovery and pre-clinical efficacy
Enikanolaiye, A., & Justice, M. J. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20180057 · Cited by 7
The Enzyme Portal: an integrative tool for enzyme information and analysis
Zaru, R., Onwubiko, J., Ribeiro, A. J. M., Cochrane, K., Tyzack, J. D., Muthukrishnan, V., Pravda, L., Thornton, J. M., O’Donovan, C., Velanker, S., et al. (2021) · FEBS Journal · doi:10.1111/febs.16168 · Cited by 7
“The use of restriction enzymes and the recent development of the CRISPR (clustered regularly interspaced short palindromic repeat) technique have revolutionized the field of molecular biology [5,6].”
MethodM−CDC: Magnetic pull-down-assisted colorimetric method based on the CRISPR/Cas12a system
Hu, M., Zhu, D., & Zhou, X. (2021) · Methods · doi:10.1016/j.ymeth.2021.11.009 · Cited by 7
RNA-Guided CRISPR-Cas9 System for Removal of Microbial Pathogens
Bhattacharjee, G., Khambhati, K., & Singh, V. (2019) · Springer eBooks · doi:10.1007/978-981-13-8739-5_12 · Cited by 9
Smith, A., Bergwell, M., Smith, E., Mathew, D., & Iyer, J. (2020) · Journal of Visualized Experiments · doi:10.3791/62001 · Cited by 10
Crystal structure of an RNA/DNA strand exchange junction
Cofsky, J. C., Knott, G. J., Gee, C. L., & Doudna, J. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263547 · Cited by 8
Self-citationDynamic RNA Nanotechnology Enters the CRISPR Toolbox
Leung, K., & Krishnan, Y. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00550 · Cited by 7
Crispr2vec: Machine Learning Model Predicts Off-Target Cuts of CRISPR systemsPreprint
Trivedi, T. B., Boger, R. S., Kamath, G. M., Evangelopoulos, G., Cate, J. H. D., Doudna, J. A., & Hidary, J. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.28.359885 · Cited by 11
Self-citationPharmacological cognitive enhancement and cheapened achievement: A new dilemma.
Gordon, E. C., & Dunn, L. (2021) · Neuroethics · doi:10.1007/s12152-021-09477-5 · Cited by 6
Harzlı, İ., Mostafa, K., Mutlu, V. A., Shamsi, I. H., & Kavas, M. (2025) · Physiologia Plantarum · doi:10.1111/ppl.70582 · Cited by 6
Multiplex Gene Editing and Effect Analysis of Yield, Fragrance, and Blast Resistance Genes in Rice
关树蕙, Han, Y., Zhang, J., Du, Y., Chen, Z., Miao, C., & Li, Y. (2026) · Genes · doi:10.3390/genes17010077 · Cited by 6
“The coding region structure, exon position, and PAM sequence availability of different genes also affect editing efficiency [37].”
The Current State and Future of Fetal Therapies
Sparks, T. N. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000651 · Cited by 8
Piot, A., El-Kassaby, Y. A., & Porth, I. M. (2022) · Current Forestry Reports · doi:10.1007/s40725-022-00162-1 · Cited by 6
Optical Penetration of Shape-Controlled Metallic Nanosensors across Membrane Barriers
Da, A., Chu, Y., Krach, J., Liu, Y., Park, Y., & Lee, S. E. (2023) · Sensors · doi:10.3390/s23052824 · Cited by 6
“Since the cell plasma membrane forms a stable impenetrable barrier, delivery of macromolecules, such as gene editing components, across membrane barriers remains a significant obstacle [1].”
BackgroundHou, F., Ke, Z., Xu, Y., Wang, Y., Zhu, G., Gao, H. C., Ji, S., & Xu, X. (2023) · Genes · doi:10.3390/genes14051091 · Cited by 6
“In recent years, CRISPR-based systems have been developed into a highly efficient technology for genome editing, including genomic deletions in cyanobacteria [10,11].”
Structural basis of negative regulation of CRISPR-Cas7-11 by TPR-CHAT
Tian, H., Luo, Q., Ma, H., Wang, X., Li, X., Shen, C., Pang, J., Wang, Y., Chen, Y., Zhang, C., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01821-4 · Cited by 6
Not just binary: embracing the complexity of nuclear division dynamics
Walsh, M. E., King, G. A., & Ünal, E. (2024) · Nucleus · doi:10.1080/19491034.2024.2360601 · Cited by 6
“With the widespread implementation of CRISPR-Cas9 editing systems, it is more feasible than ever before to study a diverse array of non-model eukaryotic organisms [66].”
BackgroundWang, Y., Zhu, J., Liu, S., Sun, Z., Wen, G., Huang, D., Chen, M., Liu, Y., & Feng, L. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s492659 · Cited by 6
“15 The CRISPR-Cas9 system targets DNA for specific identification and knockdown.”
Application of pre-amplification-based CRISPR-Cas nanostructured biosensors for bacterial detection
Zhang, H., Li, X., Gao, H., & Pan, H. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2476384 · Cited by 6
Precision, Prediction and Progress: A New Era in Pharmacology
Singh, J. P., Gaur, V., & Dubey, P. (2025) · doi:10.38124/ijisrt/25apr1322 · Cited by 7
Gerlai, R. T. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149795 · Cited by 6
Recent Advances in CRISPR/Cas9 Technology for Engineering Disease Resistance in Plants
Bhalerao, S., Okoń, S., Rai, M. K., Jadhav, P., & Prokisch, J. (2025) · Acta Agrobotanica · doi:10.5586/aa/201389 · Cited by 8
Bacterial Membrane Vesicles and Their Applications as Vaccines and in Biotechnology
Caruana, J. C., & Walper, S. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-36331-4_10 · Cited by 9
Targeted Gene Knockouts by Protoplast Transformation in the Moss Physcomitrella patens
Zhu, L. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.719087 · Cited by 6
Watanabe, K., Gee, P., & Hotta, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2772-3_22 · Cited by 6
Metabolically-targeted dCas9 expression in bacteria
Pellegrino, G. M., Browne, T. S., Sharath, K., Bari, K. A., Vancuren, S. J., Allen‐Vercoe, E., Gloor, G. B., & Edgell, D. R. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1248 · Cited by 6
Ishikawa, K., Soejima, S., & Saitoh, S. (2023) · Journal of Cell Science · doi:10.1242/jcs.261186 · Cited by 6
Modern Approaches to the Genome Editing of Antibiotic Biosynthetic Clusters in Actinomycetes
Buyuklyan, Y. A., Zakalyukina, Y. V., Osterman, I. А., & Biryukov, M. V. (2023) · Acta Naturae · doi:10.32607/actanaturae.23426 · Cited by 6
Bhattacharya, S., Agarwal, A., & Muniyappa, K. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168550 · Cited by 10
Using induced pluripotent stem cells for drug discovery in arrhythmias
Teles, D., & Fine, B. M. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2360420 · Cited by 6
“With the simultaneous improvements in gene editing, specific genetic variations could also be introduced in apparently healthy wild-type cell lines or repaired in cells obtained from donors with genetic variants to create isogenic matched pairs (Figure 1) [19–21].”
BackgroundCRISPR Advancements in Correcting Protein Misfolding: Implications for Neurodegenerative Disorders
Aslam, A., Kumar, D. J. S., Yadav, K., Yadav, A., & Ahmad, R. (2024) · Gene Expression · doi:10.14218/ge.2024.00002 · Cited by 9
Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes
Yoshimi, K., Kuno, A., Yamauchi, Y., Hattori, K., Taniguchi, H., Mikamo, K., Iida, R., Ishida, S., Goto, M., Takeshita, K., et al. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100833 · Cited by 8
The evolving landscape of NF gene therapy: Hurdles and opportunities
O’Donohue, A. K., Ginn, S. L., Burgio, G., Berman, Y. D., Dabscheck, G., & Schindeler, A. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102475 · Cited by 8
“54 Several variations of the core CRISPR-Cas9 nuclease system have been engineered that extend the technology beyond targeted gene disruption.”
Adaptation processes that build CRISPR immunity: creative destruction, updated
Lau, C. H., Reeves, R. P., & Bolt, E. L. (2019) · Essays in Biochemistry · doi:10.1042/ebc20180073 · Cited by 6
Applications of single‐cell technology on bacterial analysis
Ma, Z., Chu, P., Su, Y., Yu, Y., Wen, H., Fu, X., & Huang, S. (2019) · Quantitative Biology · doi:10.1007/s40484-019-0177-6 · Cited by 6
“We believed that more and more novel technologies would be integrated for bacterial analysis, for instance, CRISPR [85] for intracellular genetic locations and super-resolution microscopy [86] for even intracellular structures, to decipher the single cell information [87,88] and then population behaviors and community…”
BackgroundHe, L., Matošević, Z. J., Mitić, D., Markulin, D., Killelea, T., Matković, M., Bertoša, B., Ivančić-Baće, I., & Bolt, E. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062848 · Cited by 6
“Comprehensive recent perspectives of CRISPR systems can be found in [1–3], and the references therein.”
BackgroundLi, F., Song, N., Dong, Y., Li, S., Li, L., Liu, Y., Li, Z., & Yang, D. (2022) · Angewandte Chemie · doi:10.1002/ange.202116569 · Cited by 6
Molecular mechanisms of Streptococcus pyogenes Cas9: a single-molecule perspective
Zhang, Q., Chen, Z., & Sun, B. (2021) · Biophysics Reports · doi:10.52601/bpr.2021.210021 · Cited by 6
“Due to its simplicity and programmability, the Cas9 protein has been widely repurposed as an effective RNA-guided DNA-targeting platform that can easily modify the genome in various species (Knott and Doudna 2018; Zhang 2019).”
Bioeconomy and Genome Editing: A Comparison Between Germany and the Netherlands
Siebert, R., Herzig, C., & Birringer, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87402-5_11 · Cited by 6
Zhang, Z., Weng, Z., Yao, J., Liu, D., Zhang, L., Zhang, L., & Xie, G. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107340 · Cited by 6
Gene Suppression Therapies in Hereditary Cerebellar Ataxias: A Systematic Review of Animal Studies
dos Santos, C. M., Malheiro, S. F., Correia, M. A., & Damásio, J. (2023) · Cells · doi:10.3390/cells12071037 · Cited by 7
Rapid and Efficient Molecular Detection of Phytophthora nicotianae Based on RPA-CRISPR/Cas12a
Zang, J., Dai, T., Liu, T., Xu, X., & Zhou, J. (2024) · Forests · doi:10.3390/f15060952 · Cited by 6
Establishing CRISPR ‐Cas9 in the sexually dimorphic moss, Ceratodon purpureus
Tavernier, E., Lockwood, E., Perroud, P., Nogué, F., & McDaniel, S. F. (2024) · The Plant Journal · doi:10.1111/tpj.16946 · Cited by 6
A Metric Approach to Hot Topics in Biomedicine via Keyword Co-occurrence
Qin, J. H., Wang, J. J., & Ye, F. Y. (2019) · Journal of Data and Information Science · doi:10.2478/jdis-2019-0018 · Cited by 6
“The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution and CRISPR-Cas guides the future of genetic engineering (Knott & Doudna, 2018).”
Activatable CRISPR Transcriptional Circuits Generate Functional RNA for mRNA Sensing and Silencing
Ying, Z., Wang, F., Chu, X., Yu, R., & Jiang, J. (2020) · Angewandte Chemie · doi:10.1002/ange.202004751 · Cited by 6
Marine Biopolymers for Gene Delivery
Yadav, S., Jain, V. K., & Jain, K. (2022) · Springer eBooks · doi:10.1007/978-981-16-5374-2_5 · Cited by 8
Versatile and efficient genome editing with Neisseria cinerea Cas9
Liu, Z., Chen, S., Xie, W., Yu, H., Lai, L., & Li, Z. (2022) · Communications Biology · doi:10.1038/s42003-022-04258-z · Cited by 7
CRISPRi with barcoded expression reporters dissects regulatory networks in human cellsPreprint
Kim, J., Muller, R. Y., Bondra, E. R., & Ingolia, N. T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.06.611573 · Cited by 8
“CRISPR has been widely adopted due to its efficiency in perturbing genes and its flexibility in designing single guide RNAs (sgRNAs) that target specific sequences 1–3 .”
BackgroundCRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
Ma, Y., Chen, J., Du, Y., Cao, Z., Ji, W., Niu, Y., & Yang, Z. (2025) · View · doi:10.1002/viw.20250002 · Cited by 5
The Advancement of Prime Editing Technology
Zhang, L., Zhao, D., Wei, Z., Zhu, X. G., Sha, T., Tang, W., Bi, C., & Zhang, X. (2025) · ChemBioChem · doi:10.1002/cbic.202500193 · Cited by 6
Recent Advances in Cotton Transformation and Genome Editing Techniques: The Prospects and Challenges
Aluko, O. O., Ninkuu, V., Liu, Z., Qin, A., Liu, H., Yang, J., Hu, M., Ma, X., & Sun, X. (2025) · Modern Agriculture · doi:10.1002/moda.70014 · Cited by 8
“There is a growing concern about improving the target specificity of the CRISPR/Cas system resulting from off‐target activity that occurs during the development of traits in plant genomes [70].”
Hearing loss: a global view for gene therapy approaches and challenges
Elbagoury, N. M. (2025) · European Journal of Pediatrics · doi:10.1007/s00431-025-06426-9 · Cited by 5
“The most important tools are ZFNs (zinc finger nucleases) [44], TALENs (transcription activator-like effector nucleases) [45], and CRISPR/Cas9 (clustered regularly inter-spaced short palindromic repeats and CRISPR-associated protein 9) [46].”
Abdallah, N. A., Hamwieh, A., Radwan, K. H., Fouad, N., & Baum, M. (2025) · CABI biotechnology series. · doi:10.1079/9781800627307.0022 · Cited by 5
From IscB to Cas9: Engineering and advances in the next generation of miniature gene editing tools
Zhou, C., Zhu, S., Luo, C., Wang, W., Fan, H.-Q., Gao, Y., Xu, X., Wang, Q., Yu, Y., & Xie, T. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108743 · Cited by 5
Zhang, F., Peng, Y., Fan, D., Song, G., Gao, X., & Tian, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-65724-w · Cited by 7
“The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) systems as prokar-yotes ’ adaptive immune systems against invading phages or plasmids have been harnessed for diverse genome manipulation in eukaryotes 1 – 3 .”
InfluentialBennett, L. L. (2025) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040251405830 · Cited by 5
“20,21 22–24 ERTs are administered via i.v. infusion on schedules such as weekly or biweekly.”
Enzymatic crRNA stabilization strategy for enhanced CRISPR/Cas12a detection
Bai, M., Li, Y., Hu, Q., Qing, M., & Bai, L. (2026) · Talanta · doi:10.1016/j.talanta.2026.129674 · Cited by 5
Hou, Q., Ren, J., Wu, Y., Zhao, P., Yue, S., & Bi, S. (2026) · Small Methods · doi:10.1002/smtd.70666 · Cited by 5
“Over the past decades, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated (Cas) protein systems have emerged as the next-generation technology for gene editing and molecular diagnosis [ 7, 8 ].”
Epigenome editing and epigenetic gene regulation in disease phenotypes
Jin, G., & Lim, B. (2022) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-022-1076-5 · Cited by 5
Kaul, T., Verma, R., Sony, S. K., Bharti, J., Motelb, K. F. A., Prakash, A. T., Kaul, R., Nehra, M., & Eswaran, M. (2023) · Wiley eBooks · doi:10.1002/9781119858553.ch9 · Cited by 9
CRISPR Tools in Bacterial Whole-Cell Biocatalysis
Mulet, A. P., Ripoll, M., & Betancor, L. (2023) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.3c05735 · Cited by 5
Song, X., Yang, L., Lv, S., Wang, Y., Chen, L., Lu, T., Liu, F., & Peng, D. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1401038 · Cited by 6
“An emerging characterized RNA-guided and RNA-targeting CRISPR protein family, known as Cas13, offers a novel approach to manipulate RNA transcripts (Abudayyeh et al., 2017; Cox et al., 2017; Knott and Doudna, 2018).”
BackgroundCRISPR/Cas systems for genomic Editing, biochemical Sensing, Bioanalysis, and diagnostics
Baig, M. M. F. A., Chair, S. Y., & Chien, W. T. (2025) · Microchemical Journal · doi:10.1016/j.microc.2024.112638 · Cited by 5
Dynamic Genome Editing Using In Vivo Synthesized Donor ssDNA in Escherichia coli
Hao, M., Wang, Z., Qiao, H., Yin, P., Qiao, J., & Qi, H. (2020) · Cells · doi:10.3390/cells9020467 · Cited by 6
CRISPR/CAS9 IN GENOME EDITING: A NATURE GIFTED MOLECULAR TOOL
Bashir, M., Ali, Q., Rashid, M., & Malika, A. (2020) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2020i1.18 · Cited by 7
Programmable Proteins: Target Specificity, Programmability and Future Directions
Yamagata, M. (2022) · SynBio · doi:10.3390/synbio1010005 · Cited by 5
The CRISPR Revolution: Unraveling the mysteries of Life’s genetic code
Harsij, Z., Ghafoorzadeh, Z., & Goharian, E. (2023) · Gene · doi:10.1016/j.gene.2023.147870 · Cited by 5
Rao, G. S., Saleh, A. H., Melliti, F., Syed, M. M., & Mahfouz, M. M. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c05133 · Cited by 5
What can stem cell technology offer to IVF patients?
Ilić, D., Telfer, E. E., Ogilvie, C. M., Kolundžić, N., & Khalaf, Y. (2019) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15638 · Cited by 5
Programmable Assembly of DNA-protein Hybrid Structures
Li, X., Yang, D., Shen, L., Xu, F., & Wang, P. (2019) · Chemical Research in Chinese Universities · doi:10.1007/s40242-019-0038-x · Cited by 5
Research progress of pathway and genome evolution in microbes
Huang, C., Wang, C., & Luo, Y. (2022) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2022.01.004 · Cited by 5
Snapshots of a tiny ancestral nuclease of Cas9
Hou, Z., Tan, R., & Zhang, Y. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.08.008 · Cited by 5
McDiarmid, T. A., Au, V., Moerman, D. G., & Rankin, C. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238950 · Cited by 6
From Personalized to Precision Cancer Medicine
Baltagiannis, E. G., Kyrochristos, I. D., Ziogas, D. E., GOUSSIA, A. C., Mitsis, M. C., & Roukos, D. H. (2020) · Personalized Medicine · doi:10.2217/pme-2020-0056 · Cited by 5
All-in-one AAV-mediated Nrl gene inactivation rescues retinal degeneration in Pde6a mice
Liu, Z., Chen, S., Lo, C., Wang, Q. K., & Sun, Y. (2024) · JCI Insight · doi:10.1172/jci.insight.178159 · Cited by 4
Wu, D., Snead, S., Ganguly, C., Babu, K., Li, Y., Kathiresan, V., Shen, R., Zhang, X., Rajan, R., & Qin, P. Z. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf557 · Cited by 4
Scaling up microbial drug production: strategies to overcome key challenges
Paul, D., & Sarkar, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33032-2.00006-x · Cited by 4
Causal Structure and Representation Learning with Biomedical Applications
Uhler, C. (2026) · Volume 7: Invited Lectures: Sections 15–20 · doi:10.1137/25m1805849 · Cited by 4
Emerging CRISPR/Cas-Based Strategies for Extracellular Vesicle Detection: A Comprehensive Review
Chen, W., Fan, L., Dong, M., Gao, L., Du, X., Wang, L., Su, S., Liu, L.-E., Wu, Y., & Ding, L. (2025) · ACS Sensors · doi:10.1021/acssensors.5c02441 · Cited by 4
Zhang, J., Liu, Y.-R., Cao, W., Ruan, R., & Wang, M. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c11144 · Cited by 4
Yu, K., Li, H., Hu, Y., Yu, Y., Deng, S., Yang, Y., Guo, M., Li, M., Zhe, M., He, H., et al. (2026) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiag032 · Cited by 4
Accelerated CRISPR/Cas12a‐Based Point‐of‐Care Diagnostics Through Critical Coupling Distance Control
Su, T., Zhu, D., Li, X., Qu, Z., Li, F., Zhao, D., Shao, G., Feng, Z., Su, S., Chao, J., et al. (2026) · Advanced Materials · doi:10.1002/adma.202523381 · Cited by 5
A kinetic approach for mapping seed regions of CRISPR ribonucleoprotein and improving specificity
Feng, W., Hu, J., Zhang, H., & Le, X. C. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag413 · Cited by 4
“S1 ) [ 4 ].”
A New RNA-Dependent Cas12g Nuclease
Gunitseva, N. M., Evteeva, M. A., Korzhenkov, A. A., & Patrushev, M. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317105 · Cited by 4
Mahmood, M., Taufiq, I., Mazhar, S., Hafeez, F., Malik, K. A., & Afzal, S. (2024) · Personalized Medicine · doi:10.1080/17410541.2024.2341610 · Cited by 5
CRISPR-Mediated Viral Gene Knockout to Investigate Viral Evasion of Antiviral Innate Immunity
Feng, Z., Shen, Y., Zheng, C., & Chen, Q. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4108-8_6 · Cited by 4
Reporter Mice for Gene Editing: A Key Tool for Advancing Gene Therapy of Rare Diseases
Li, S.-A., & Brakebusch, C. (2024) · Cells · doi:10.3390/cells13171508 · Cited by 4
“Among the various naturally evolved CRISPR-Cas systems, the type II DNA-targeting endonuclease Cas9 is Among the various naturally evolved CRISPR-Cas systems, the type II DNA-targeting endonuclease Cas9 is most widely used for genome engineering [13]. most widely used for genome engineering [13].”
BackgroundLeveraging next-generation technologies to enhance systemic acquired resistance (SAR) in fruit trees
Ramekar, S., & Dutt, M. (2025) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-024-02944-w · Cited by 4
“Both systems can cleave double-stranded DNA (dsDNA) with a single Cas protein (Cas9 or Cas12) required for DNA recognition and cleavage (Knott et al. 2018).”
Leveraging CRISPR/Cas9 in notable bacteria for the production of industrially valuable compounds
Karim, M. D., Abuhena, M., Rahman, L., & Al-Rashid, J. (2025) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-024-00326-z · Cited by 4
“The first Cas9 protein, SpCas9, from Streptococcus pyogenes , is the most frequent Cas nuclease used to change genomes [23 , 24 ].”
Zhao, W., Zhu, X., Huang, G., Gu, H., Bi, Y., Tang, D., & Ren, H. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.28931 · Cited by 4
“In the latter pathway, DSBs are rapidly repaired by joining broken DNA strands (Knott and Doudna 2018; Mikkelsen and Bak 2023).”
Kitenge, S. Y., Nkhabindze, B. Z., Ratemo, B. O., Dada, S. A., Ogbimi, E. R., Karikari, B., Nuaila, V. N. A., Toili, M. E. M., Ndudzo, A., Adetunji, C. O., et al. (2025) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2025.1530800 · Cited by 4
Genome Editing Technologies to Improve Health‐Related Phytocompounds in Crops
Dellino, M., Giovanni, C. D., Miazzi, M. M., Montemurro, C., & Nigro, D. (2025) · Food Frontiers · doi:10.1002/fft2.70005 · Cited by 4
CRISPR-Cas13 as an Antiviral Strategy for Coronavirus Disease 2019
Zhang, Y. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.29094.yzh · Cited by 4
No apparent p53 activation in CRISPR‐engineered gene‐edited rabbits
Zhang, T., Li, J., Wang, T., Zhao, F., & Sui, T. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16960 · Cited by 4
“We grouped these rabbits as follows: (1) the genome editing rabbits generated with DSB by CRISPR- Cas9; (2) the genome editing rabbit generated without DSB by BEs.”
Method
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.